Paloma Partners Management CO Abbott Laboratories Put Options Transaction History

Paloma Partners Management CO

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $2.84 Million - $3.35 Million	28,400 Added 75.73%	65,900 $7.51 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.78 Million - $4.22 Million	37,500 New	37,500 $3.9 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $6.11 Million - $7.34 Million	64,000 Added 166.67%	102,400 $9.92 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.87 Million - $3.2 Million	-28,500 Reduced 42.6%	38,400 $4.19 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $6.48 Million - $7.63 Million	66,900 New	66,900 $6.77 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2.02 Million - $2.34 Million	20,900 New	20,900 $2.02 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $337,593 - $375,820	-4,300 Reduced 12.25%	30,800 $2.68 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $6.02 Million - $6.52 Million	-73,500 Reduced 67.68%	35,100 $2.94 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $7.19 Million - $8.69 Million	108,600 New	108,600 $8.68 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $3.92 Million - $4.44 Million	-59,800 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $948,636 - $1.14 Million	15,600 Added 35.29%	59,800 $4.39 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $1.77 Million - $2 Million	-31,500 Reduced 41.61%	44,200 $2.65 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $4.06 Million - $4.35 Million	75,700	75,700 $4.32 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.